person · Reporting owner
Abbott Swati Bargotra
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ENSIGN GROUP, INCENSG · Entity 3521 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ENSIGN GROUP, INC
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,832 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 600 · Balance 20,832 F1: These shares vest in three equal annual installments beginning July 15, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares vest in three equal annual installments beginning July 15, 2027.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MAGELLAN HEALTH INC
Report date January 04, 2022 · Filed January 04, 2022
Section 16 reporting ended · disclosed 2022-01-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-01-04 transaction · row 1
1 source rowRow 1 · 2022-01-04 · Disposition to issuer · Disposed 6,847 · Balance 0 F1: In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among the Issuer, Centene Corporation ("Centene") and Mayflower Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the "Merger Consideration"). F2: Includes 2,911 restricted shares of Common Stock. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each of these restricted shares of Common Stock was automatically cancelled and converted into the right to receive the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among the Issuer, Centene Corporation ("Centene") and Mayflower Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the "Merger Consideration").
F2: Includes 2,911 restricted shares of Common Stock. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each of these restricted shares of Common Stock was automatically cancelled and converted into the right to receive the Merger Consideration.
Talkspace, Inc.
Report date August 17, 2026 · Filed August 17, 2026
Section 16 reporting ended · disclosed 2026-08-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-08-17 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2026-08-17 · Disposition to issuer · Disposed 92,866 · Balance 0 F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F2: Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding share of Issuer common stock, par value $0.0001 per share ("Common Stock") (other than shares of Common Stock canceled pursuant to the Merger Agreement) was converted into the right to receive $5.25 in cash (the "Merger Consideration"). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-08-17 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2026-08-17 · Disposition to issuer · Disposed 78,830 · Balance 0 F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F3: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer restricted stock unit that was or became vested in accordance with its terms at the Effective Time (each, a "Vested RSU") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested RSU immediately prior to the Effective Time and (ii) the Merger Consideration. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.27 | Direct | 0 |
Reported balance
After 2026-08-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-17 · Disposition to issuer · Disposed 57,985 · Balance 0 F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F4: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer stock option that was or became vested in accordance with its terms at the Effective Time (each, a "Vested Stock Option") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (a) the Merger Consideration over (b) the per share exercise price of such Vested Stock Option. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time").
F2: Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding share of Issuer common stock, par value $0.0001 per share ("Common Stock") (other than shares of Common Stock canceled pursuant to the Merger Agreement) was converted into the right to receive $5.25 in cash (the "Merger Consideration").
F3: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer restricted stock unit that was or became vested in accordance with its terms at the Effective Time (each, a "Vested RSU") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested RSU immediately prior to the Effective Time and (ii) the Merger Consideration.
F4: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer stock option that was or became vested in accordance with its terms at the Effective Time (each, a "Vested Stock Option") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (a) the Merger Consideration over (b) the per share exercise price of such Vested Stock Option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2026 Filed Aug 17, 2026 14:15 UTC | Talkspace, Inc. TALK · Entity 22747 | Disposition to issuerStock Options · Derivative | 57,985 | Not disclosed Strike: $2.27 | Not disclosed |
DisclosureSEC source: 0001193125-26-353424 · ownership.xml · derivative · entry 3 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,985 shares Expires not disclosed F1 · price: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F4 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer stock option that was or became vested in accordance with its terms at the Effective Time (each, a "Vested Stock Option") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (a) the Merger Consideration over (b) the per share exercise price of such Vested Stock Option. F1 · derivative.exercise_date: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F4 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer stock option that was or became vested in accordance with its terms at the Effective Time (each, a "Vested Stock Option") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (a) the Merger Consideration over (b) the per share exercise price of such Vested Stock Option. F1 · derivative.expiration_date: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F4 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer stock option that was or became vested in accordance with its terms at the Effective Time (each, a "Vested Stock Option") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested Stock Option immediately prior to the Effective Time and (ii) the excess, if any, of (a) the Merger Consideration over (b) the per share exercise price of such Vested Stock Option. Read SEC document |
| August 17, 2026 Filed Aug 17, 2026 14:15 UTC | Talkspace, Inc. TALK · Entity 22747 | Disposition to issuerCommon Stock | 78,830 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-353424 · ownership.xml · nonDerivative · entry 2 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F3 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer restricted stock unit that was or became vested in accordance with its terms at the Effective Time (each, a "Vested RSU") was canceled and converted into the right to receive a cash payment equal to the product of (i) the number of shares of Common Stock subject to such Vested RSU immediately prior to the Effective Time and (ii) the Merger Consideration. Read SEC document |
| August 17, 2026 Filed Aug 17, 2026 14:15 UTC | Talkspace, Inc. TALK · Entity 22747 | Disposition to issuerCommon Stock | 92,866 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-353424 · ownership.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: In connection with the terms of that certain Agreement and Plan of Merger, dated as of March 9, 2026 (the "Merger Agreement"), by and among Talkspace, Inc., a Delaware Corporation (the "Issuer"), Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as an indirect wholly owned subsidiary of Parent at the effective time of the Merger (the "Effective Time"). F2 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding share of Issuer common stock, par value $0.0001 per share ("Common Stock") (other than shares of Common Stock canceled pursuant to the Merger Agreement) was converted into the right to receive $5.25 in cash (the "Merger Consideration"). Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:22 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001741453-26-000006 · wk-form4_1784319753.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,832 F1 · shares: These shares vest in three equal annual installments beginning July 15, 2027. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 22:48 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001741453-26-000004 · wk-form4_1776466078.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,232 F1 · shares: These shares vest in three equal annual installments beginning April 15, 2027. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 21:27 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001741453-26-000002 · wk-form4_1768944440.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,632 F1 · shares: These shares vest in three equal annual installments beginning January 15, 2027. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 02:30 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantCommon Stock | 48,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-305731 · ownership.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,696 F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in full on the one-year anniversary of December 1, 2025, subject to continued service through the applicable vesting date. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 20:44 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001741453-25-000005 · wk-form4_1760733849.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,032 F1 · shares: These shares vest in three equal annual installments beginning October 15, 2026. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:18 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-25-000131 · wk-form4_1752783476.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,432 F1 · shares: These shares vest in three equal annual installments beginning July 15, 2026. Read SEC document |
| April 15, 2025 Filed Apr 17, 2025 20:22 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-25-000066 · wk-form4_1744921369.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,832 F1 · shares: These shares vest in three equal annual installments beginning April 15, 2026. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:54 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-25-000011 · wk-form4_1737150857.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,232 F1 · shares: These shares vest in three equal annual installments beginning January 15, 2026. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:47 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GiftCommon Stock | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-24-000192 · wk-form4_1733348834.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,632 Read SEC document |
| December 01, 2024 Filed Dec 13, 2024 13:43 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantCommon Stock | 46,839 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136053 · ownership.xml · nonDerivative · entry 2 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,474 F2 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in full on the one-year anniversary of December 1, 2024, subject to continued service through the applicable vesting date. Read SEC document |
| December 01, 2024 Filed Dec 13, 2024 13:43 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantCommon Stock | 2,928 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136053 · ownership.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,635 F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in full on the grant date, December 1, 2024. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 22:39 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-24-000160 · wk-form4_1729204771.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,667 F1 · shares: These shares vest in three equal annual installments beginning October 15, 2025. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:14 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | SaleCommon Stock | 1,000 | $152.45 | $152,450.00 |
DisclosureSEC source: 0001125376-24-000154 · wk-form4_1726604047.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,067 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2024. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 22:29 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantCommon Stock | 5,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-040101 · form4.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,707 F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in full on the grant date, September 1, 2024. Read SEC document |
| July 15, 2024 Filed Jul 15, 2024 23:36 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-24-000126 · wk-form4_1721086586.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,067 F1 · shares: These shares vest in three equal annual installments beginning July 15, 2025. Read SEC document |
| June 01, 2024 Filed Jun 27, 2024 01:04 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantCommon Stock | 3,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-031471 · form4.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,313 F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in full on the grant date, June 1, 2024. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 22:18 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-24-000049 · wk-form4_1713392289.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,192 F1 · shares: These shares vest in three equal annual installments beginning April 15, 2025. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 01:13 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantCommon Stock | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-011514 · form4.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,652 F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in full on the grant date, March 1, 2024. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 22:48 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-24-000014 · wk-form4_1705618104.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,317 F1 · shares: These shares vest in three equal annual installments beginning January 16, 2025. Read SEC document |
| December 01, 2023 Filed Dec 7, 2023 22:50 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantStock Options · Derivative | 57,985 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001140361-23-056696 · form4.xml · derivative · entry 2 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,985 Underlying: Common Stock · 57,985 shares Expires 2033-12-01 F2 · derivative.exercise_date: The stock option vests in 4 equal annual installments beginning on December 1, 2024. Read SEC document |
| December 01, 2023 Filed Dec 7, 2023 22:50 UTC | Talkspace, Inc. TALK · Entity 22747 | GrantCommon Stock | 61,215 | $2.04 | $124,878.60 |
DisclosureSEC source: 0001140361-23-056696 · form4.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,215 F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in four equal annual installments beginning on December 1, 2024. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 21:23 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-23-000179 · wk-form4_1697664228.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,442 F1 · shares: These shares vest in three equal annual installments beginning October 16, 2024. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 21:20 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-23-000137 · wk-form4_1689801648.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,567 F1 · shares: These shares vest in three equal annual installments beginning July 17, 2024. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 22:41 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-23-000081 · wf-form4_168194408348204.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,692 F1 · shares: These shares vest in three equal annual installments beginning April 17, 2024. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 23:21 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-23-000006 · wf-form4_167417048337416.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,817 F1 · shares: These shares vest in three equal annual installments beginning January 17, 2024. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 23:15 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-22-000129 · wf-form4_166613488766922.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,942 F1 · shares: These shares vest in three equal annual installments beginning October 17, 2023. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 21:05 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-22-000102 · wf-form4_165826467915521.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,067 F1 · shares: These shares vest in three equal annual installments beginning July 15, 2023. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 22:30 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-22-000070 · wf-form4_165049383129955.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,192 F1 · shares: These shares vest in three equal annual installments beginning April 18, 2023. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:14 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-22-000008 · wf-form4_164271682782238.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 F1 · shares: These shares vest in three equal annual installments beginning January 18, 2023. Read SEC document |
| January 04, 2022 Filed Jan 4, 2022 17:01 UTC | MAGELLAN HEALTH INC MGLN · Entity 131790 | Disposition to issuerOrdinary Common Stock, $0.01 par value | 6,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000946 · doc4.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among the Issuer, Centene Corporation ("Centene") and Mayflower Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the "Merger Consideration"). F2 · kind: Includes 2,911 restricted shares of Common Stock. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each of these restricted shares of Common Stock was automatically cancelled and converted into the right to receive the Merger Consideration. F2 · shares: Includes 2,911 restricted shares of Common Stock. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each of these restricted shares of Common Stock was automatically cancelled and converted into the right to receive the Merger Consideration. F1 · price: In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among the Issuer, Centene Corporation ("Centene") and Mayflower Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the "Merger Consideration"). F2 · price: Includes 2,911 restricted shares of Common Stock. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each of these restricted shares of Common Stock was automatically cancelled and converted into the right to receive the Merger Consideration. Read SEC document |
| November 19, 2021 Filed Feb 15, 2022 00:05 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GiftCommon Stock | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-22-000040 · wf-form5_164488346846921.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,442 Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 22:40 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-21-000145 · wf-form4_163468320532642.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,625 F1 · shares: These shares vest in three equal annual installments beginning October 15, 2022. Read SEC document |
| August 13, 2021 Filed Aug 13, 2021 16:32 UTC | MAGELLAN HEALTH INC MGLN · Entity 131790 | GrantOrdinary Common Stock, $0.01 par value | 789 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051402 · doc4.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,847 F1 · shares: One half of the annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the first anniversary of the grant date, subject to earlier acceleration or forfeiture. F2 · price: Not applicable. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 23:20 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-21-000115 · wf-form4_162647759275044.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 F1 · shares: These shares vest in three equal annual installments beginning July 15, 2022. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 22:27 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-21-000067 · wf-form4_161861203081706.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 F1 · shares: These shares vest in three equal annual installments beginning April 15, 2022. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 00:00 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-21-000012 · wf-form4_161118722485918.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 F1 · shares: These shares vest in three equal annual installments beginning January 15, 2022. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 22:32 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-20-000172 · wf-form4_160288752662533.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 F1 · shares: This restricted stock award vests in three equal annual installments beginning October 15, 2021 Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 22:29 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001125376-20-000113 · wf-form4_159502495805542.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 F1 · shares: This restricted stock award vests in three equal annual installments beginning July 15, 2021 Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 16:24 UTC | MAGELLAN HEALTH INC MGLN · Entity 131790 | GrantOrdinary Common Stock, $0.01 par value | 2,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037930 · doc4.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,058 F1 · shares: Annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the date of the 2021 Annual Meeting of Shareholders. F2 · price: Not applicable. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 22:22 UTC | ENSIGN GROUP, INC ENSG · Entity 3521 | GrantCommon Stock | 1,125 | $35.47 | $39,903.75 |
DisclosureSEC source: 0001125376-20-000071 · wf-form4_158716210497053.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125 F1 · shares: These shares vest in three equal annual installments beginning April 15, 2021. Read SEC document |
| June 21, 2019 Filed Jun 24, 2019 19:32 UTC | MAGELLAN HEALTH INC MGLN · Entity 131790 | GrantOrdinary Common Stock, $0.01 par value | 2,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038847 · doc4.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,936 F1 · shares: Annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the date of the 2020 Annual Meeting of Shareholders. F2 · price: Not applicable. Read SEC document |
| May 24, 2018 Filed May 25, 2018 17:12 UTC | MAGELLAN HEALTH INC MGLN · Entity 131790 | GrantOrdinary Common Stock, $0.01 par value | 1,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033572 · doc4.xml · nonDerivative · entry 1 Abbott Swati Bargotra · CIK 0001741453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,685 F1 · shares: Annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the date of the 2019 Annual Meeting of Shareholders. F2 · price: Not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.